Search

everythinglearnresearchcommunity

for

Search:↓

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Dutasteride and finasteride affect different cell types differently.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Mutations in certain receptors can cause diseases and offer new treatment options.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

AR gene variations don't affect aging markers in men.

Gene variation affects prostate issues and hair loss.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

COVID-19 may worsen with androgens; anti-androgen drugs could help.